Intrinsic Value of S&P & Nasdaq Contact Us

American Well Corporation AMWL NYSE

NYSE • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
40/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.00
-9.3%

American Well Corporation (AMWL) reported total assets of $323.79M and total liabilities of $76M for fiscal year 2025, resulting in total equity of $247.79M.

The company held $182.33M in cash and short-term investments. Total debt stood at $4.52M, with net debt of $-177.8M. The Debt-to-Equity (D/E) ratio was 0.02 (conservative).

Current ratio is 3.37, indicating strong short-term liquidity.

Criteria supported by this page:

  • HEALTH (100/100, Pass) — Debt-to-Equity of 0.02, current ratio of 3.37 — balance sheet is strong
  • MOAT (58/100) — Total assets $323.79M and equity $247.79M support the company's competitive scale
  • VALUE (73/100) — Debt-to-Equity 0.02 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 40/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
40/100
SG Score
View full scorecard →
VALUE
73/100
Price-to-Earnings & upside
→ Valuation
FUTURE
26/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
58/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income
American Well Corporation Balance Sheet History
Metric FY2025 FY2024 FY2023 FY2022
Total Assets $323.79M$435.97M$589.71M$1.22B
Total Liabilities $76M$119.72M$109.52M$133.71M
Total Debt $4.52M$8.2M$11.79M$14.84M
Cash & Investments $182.33M$228.32M$372.04M$538.55M
Total Stockholders Equity $235.58M$304.77M$464.22M$1.06B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message